Novel site-specific photodegradation alters amino acids in antibody proteins, suggesting stability improvements for therapeutics.
Near-UV and visible-light photodegradation is a concern for the development of stable and efficacious protein therapeutics, but mechanistic information on the underlying processes is scarce. We previously reported on the photoconversion and photofragmentation of IgG1-Fc, IgG1, and an IgG1-based fusion protein in the CH₂ domain. Here, we report a novel site-specific photodegradation mechanism, converting Thr into Ala catalyzed by Fe(III). Site-directed mutagenesis and spin-trapping in conjunction with high pressure liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) analysis reveal that this novel photoconversion proceeds via the generation of intermediary protein glycyl and methyl (•CH₃) radicals analogous to metal-catalyzed cross-coupling reactions observed in synthetic organic processes.
No takes yet. Share an insight, caveat, or question.
Ballesteros et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: